BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 21267687)

  • 1. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Ewing sarcoma of the brain: a case report and literature review.
    Kazmi SA; Perry A; Pressey JG; Wellons JC; Hammers Y; Palmer CA
    Diagn Mol Pathol; 2007 Jun; 16(2):108-11. PubMed ID: 17525681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral primitive neuroectodermal tumor/Ewing's sarcoma of the craniospinal vault: case reports and review.
    Mobley BC; Roulston D; Shah GV; Bijwaard KE; McKeever PE
    Hum Pathol; 2006 Jul; 37(7):845-53. PubMed ID: 16784984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
    Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
    Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.
    Amann G; Zoubek A; Salzer-Kuntschik M; Windhager R; Kovar H
    Hum Pathol; 1999 Sep; 30(9):1058-64. PubMed ID: 10492040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
    Uren A; Toretsky JA
    Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
    Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
    Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of the in situ hybridization with EWS dual-color break-apart fluorescence probe and anti-CD99 and anti-FLI-1 antibodies in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor].
    Liu BY; Yang Y; DU J; Zhang Y; Wang H; Zheng J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):358-62. PubMed ID: 18677380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ewing sarcoma family of tumors.
    Khoury JD
    Adv Anat Pathol; 2005 Jul; 12(4):212-20. PubMed ID: 16096383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing sarcoma/primitive neuroectodermal tumor of the kidney: clinicopathologic analysis of 34 cases.
    Karpate A; Menon S; Basak R; Yuvaraja TB; Tongaonkar HB; Desai SB
    Ann Diagn Pathol; 2012 Aug; 16(4):267-74. PubMed ID: 22534242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
    de Alava E; Panizo A; Antonescu CR; Huvos AG; Pardo-Mindán FJ; Barr FG; Ladanyi M
    Am J Pathol; 2000 Mar; 156(3):849-55. PubMed ID: 10702401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
    Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
    Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.
    Amaral AT; Manara MC; Berghuis D; Ordóñez JL; Biscuola M; Lopez-García MA; Osuna D; Lucarelli E; Alviano F; Lankester A; Scotlandi K; de Álava E
    PLoS One; 2014; 9(2):e85814. PubMed ID: 24498265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 is an oncogenic mediator in Ewing Sarcoma.
    Christensen L; Joo J; Lee S; Wai D; Triche TJ; May WA
    PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative EWS-FLI1 fusion gene and MIC2 expression in peripheral and central primitive neuroectodermal tumors.
    Ishii N; Hiraga H; Sawamura Y; Shinohe Y; Nagashima K
    Neuropathology; 2001 Mar; 21(1):40-4. PubMed ID: 11304041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
    Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
    Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
    Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ
    J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.
    Llombart-Bosch A; Machado I; Navarro S; Bertoni F; Bacchini P; Alberghini M; Karzeladze A; Savelov N; Petrov S; Alvarado-Cabrero I; Mihaila D; Terrier P; Lopez-Guerrero JA; Picci P
    Virchows Arch; 2009 Nov; 455(5):397-411. PubMed ID: 19841938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues.
    Lewis TB; Coffin CM; Bernard PS
    Mod Pathol; 2007 Mar; 20(3):397-404. PubMed ID: 17334332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.